Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ovid Therapeutics Inc. | CEO, Director | Common Stock | 3.62M | $9.98M | $2.76 | Mar 18, 2024 | Direct |
Ovid Therapeutics Inc. | CEO, Director | Common Stock | 35.5K | $97.9K | $2.76 | Mar 18, 2024 | Indirect |
Ovid Therapeutics Inc. | CEO, Director | Stock Option (Right to Buy) | 700K | Feb 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OVID | Ovid Therapeutics Inc. | Mar 18, 2024 | 1 | $50.4K | 4 | Mar 20, 2024 | CEO, Director |
OVID | Ovid Therapeutics Inc. | Feb 22, 2024 | 1 | $0 | 4 | Feb 26, 2024 | CEO, Director |
OVID | Ovid Therapeutics Inc. | Dec 4, 2023 | 2 | $0 | 4 | Dec 6, 2023 | CEO, Director |
OVID | Ovid Therapeutics Inc. | Feb 23, 2023 | 1 | $0 | 4 | Feb 27, 2023 | CEO, Director, 10%+ Owner |
OVID | Ovid Therapeutics Inc. | Apr 8, 2022 | 1 | $0 | 4 | Apr 12, 2022 | CEO, Director, 10%+ Owner |
OVID | Ovid Therapeutics Inc. | Feb 3, 2022 | 1 | $0 | 4 | Feb 4, 2022 | CEO, Director, 10%+ Owner |
OVID | Ovid Therapeutics Inc. | Oct 8, 2019 | 1 | $0 | 4/A | Feb 14, 2024 | CEO, Director |